Press Releases Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq Other stock markets 04:00:03 2024-05-31 pm EDT			5-day change	1st Jan Change
5.875 ^USD	+2.17%		+13.86%	-53.92%

May. 29	Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing	MT
May. 17	North American Morning Briefing : The "Everything -2-	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI	May. 30	PR
Treace to Present at Truist Securities MedTech Conference	May. 28	AQ
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI	May. 22	PR
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Treace Medical Concepts, Inc. (TMCI)	May. 17	BU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI	May. 16	PR
Treace Medical Concepts: Q1 Earnings Snapshot	May. 07	AQ
Treace Medical Concepts Reports First Quarter 2024 Financial Results	May. 07	AQ
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour	Apr. 24	AQ
Treace to Present at Bank of America Health Care Conference	Apr. 17	GL
Treace Announces First Annual National Bunion Day	Apr. 16	GL
Treace to Report First Quarter 2024 Financial Results	Apr. 09	GL
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone	Mar. 25	GL
Treace Medical Concepts: Q4 Earnings Snapshot	Feb. 27	AQ
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance	Feb. 27	GL
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results	Feb. 07	GL
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure	Feb. 02	GL
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference	Feb. 01	GL
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference	Feb. 01	AQ
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue	Jan. 08	GL
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue	Jan. 08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Press Releases

Filters